ACS Journal Cancer shared on X:
“In the latest Cancer Scope, attention is given to promising findings recently published in NEJM, which show the potential for ponsegromab as a novel, targeted therapy to address unmet needs of patients with cancer and cachexia.”
Authors: Mary Beth Nierengarten
